CD8A and cancer: The combined approach of ferroptosis, immune checkpoint inhibition (via PD-L1 downregulation), and activation of critical immune cells such as dendritic cells (DCs), natural killer (NK) cells, and CD8 + T cells forms a compelling foundation for future exploration in cancer immunotherapy.